uk en
LIFE SCIENCES LAWYERS | UKRAINE & CIS
Menu

LA LAW FIRM (Legal Alliance) founded in 1995, is today one of the leading Ukrainian law firms that provides comprehensive corporate counselling and practical support to national and global companies in Ukraine, СEE & Central Asia..

OUR CLIENTS represent life sciences industries including healthcare and pharmaceuticals, medical devices, cosmetics, biotechnology as well as healthcare institutions.

LEADING ASSOCIATIONS — AIPM Ukraine, APRaD as well as the EBA Healthcare Committee have chosen LA Law Firm as their legal advisor.

616
Recently, the Ukrainian Bar Association (UBA) Committee held a meeting on the topic ‘Ukrainian Bolar: efficiency and ways to improve’.
862
590
Dmytro Aleshko, managing partner of LA Law Firm, took part in the forum as a speaker. - The results of the forum, Apteka.ua
640
LA Law Firm held the webinar highlighting key regulatory changes in the pharmaceutical sector, in particular in the Health Technology Assessment (HTA)​ procedure, Managed Entry Agreement (MEA)​, parallel import, regulatory changes in the circulation of dietary supplements, etc.​
760
The publishing house "Yuridychna Praktika" announced the twenty-first issue of Ukrainian Law Firms. A Handbook for Foreign Clients
520
We continue to inform our readers about the events of the annual XIII Congress "Pharmacies of the World-2024", which took place in Kyiv with the participation of more than 300 pharmaceutical professionals from all over Ukraine and abroad.
1045
This year's WWL: Life Sciences once again recognized LA Law Firm managing partner among the leaders.
929
The pharmaceutical market is always in the focus of attention of the Antimonopoly Committee of Ukraine (AMCU) due to its social importance. A number of specific features of this market add additional challenges.
1700
According to the results of the recently published international study The Legal 500 Europe, Middle East & Africa 2024 LA Law Firm is recognized among the leading law firms of Ukraine.
1266
LA Law Firm held a webinar "Regulatory changes for pharmaceutical sector in 2024. Conclusions and forecasts". During the event, the participants discussed changes in the Health Technology Assessment procedure, regulation of prices for medicines, the Prozorro Market Electronic Catalogue, regulatory plans to change approaches to the circulation of dietary supplements, etc.
If you find out a mistake, please, mark it and select Ctrl+Enter to inform us